Sarah Maxfield
Global Vice President, Commercial Development
Email
Email Sarah to schedule a meeting!
By reaching out to FUJIFILM Diosynth Biotechnologies (FDB), you agree to allow FDB to contact your for purposes of scheduling a meeting at JPM.
We are your end-to-end provider to support your medicine's journey through the regulatory pathway and product life cycle.
Drug Substance
Drug Product
Finished Goods
JPM Week 2024
Schedule a Meeting
Learn more
As your global CDMO partner we offer complete solutions in pharmaceutical manufacturing that adapt to your rapidly changing needs – from pre-clinical investigations and process development to flexible commercial cGMP production.
Learn more
FUJIFILM Diosynth Biotechnologies is delighted to be attending the 42nd Annual J.P. Morgan Healthcare Conference, the industry's largest investor symposium, with over 500 companies and thousands of institutional investors participating in ancillary industry events that accompany this week.
We look forward to this time to build relationships with our customers and partners.
We aim to be your partner through trust, transparency, collaboration, innovation, and quality.
Our Committment to Patients
Click to learn more
Reliability
Quality
Knowledge
Operational
Philosophy
Biomanufacturing eco-system that enables agile supply chains with our partners.
We consistentlydeliver for you.
We are the experts in our field.
Committed to the highest level of quality across processes and network.
Advancing tomorrow’s medicines across all modalities throughout the entire drug development journey
Cell Culture Cell Therapy Gene Therapy Vaccines Microbial
![](https://media-s3-us-east-1.ceros.com/fujifilm-diosynth/images/2023/12/15/978486f037c881e155969372c5d0370f/green-cell-only-copy.png)